New breast cancer treatment offers hope of longer life to younger women
by Jamie Doward from Science | The Guardian on (#4GA68)
Combining ribociclib with hormone therapy found to cut risk of death by up to a third
Younger women with breast cancer have been given the hope of living longer after what is described as "one of the greatest advances in breast cancer research in recent decades".
Adding ribociclib, a targeted drug that disrupts cancer cells, to standard hormone therapy was found to boost survival among premenopausal patients who have an advanced form of the disease.
Continue reading...